Glycation Endproducts, Soluble Receptor for Advanced Glycation Endproducts and Cytokines in Diabetic and Non-diabetic Pregnancies

被引:32
|
作者
Pertynska-Marczewska, Magdalena
Glowacka, Ewa [2 ]
Sobczak, Malgorzata [1 ]
Cypryk, Katarzyna [3 ]
Wilczynski, Jan
机构
[1] RI PMMH, Foetal Maternal Med & Gynaecol Dept, Specialized Outpatient Clin, PL-93338 Lodz, Poland
[2] RI PMMH, Dept Clin Immunol, PL-93338 Lodz, Poland
[3] Med Univ Lodz, Dept Diabetol & Metab Dis, Lodz, Poland
关键词
Diabetes type 1; glycation endproducts; maternal immune system; soluble receptor for advanced glycation endproducts; NECROSIS-FACTOR-ALPHA; END-PRODUCTS SRAGE; FACTOR-KAPPA-B; SERUM-LEVELS; INFLAMMATORY MARKERS; RAGE; ASSOCIATION; EXPRESSION; CELLS; FORM;
D O I
10.1111/j.1600-0897.2008.00679.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytokines, advanced glycation end products (AGEs), and their receptor RAGE have been recently suggested to play a role in human pregnancy. In this study, we sought to determine the alterations of plasma AGEs, soluble RAGE (sRAGE), and proinflammatory cytokines in normal pregnancies and those complicated with type 1 diabetes mellitus. These parameters were measured in samples from healthy non-pregnant (C), diabetic non-pregnant (D), healthy pregnant (HP), and pregnant diabetic (DP) women. In the first trimester, DP showed lower sRAGE and higher AGEs compared to HP. In the DP group, significant negative correlations were seen between TNF-alpha and lipopolysaccharide (LPS)-stimulated Iota L-6 in the first trimester and sRAGE in the third trimester. LPS-stimulated IL-12 was positively correlated with levels of AGEs in the third trimester. We detected several differences in the levels of AGEs, sRAGE, and proinflammatory cytokines between euglycemic and diabetic pregnancies.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 50 条
  • [31] Advanced glycation endproducts and osteoarthritis
    Deborah M. Saudek
    Jonathan Kay
    Current Rheumatology Reports, 2003, 5 (1) : 33 - 40
  • [32] Polymorphisms of the Receptor of Advanced Glycation Endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients
    Prevost, G
    Fajardy, I
    Besmond, C
    Balkau, B
    Tichet, J
    Fontaine, P
    Danze, PM
    Marre, M
    DIABETES & METABOLISM, 2005, 31 (01) : 35 - 39
  • [33] Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls
    Fokkens, Bernardina T.
    Mulder, Douwe J.
    Schalkwijk, Casper G.
    Scheijen, Jean L.
    Smit, Andries J.
    Los, Leonoor I.
    PLOS ONE, 2017, 12 (03):
  • [34] LEVELS OF ADVANCED GLYCATION ENDPRODUCTS (AGES) IN DIABETES - POSSIBLE ROLE IN DIABETIC COMPLICATIONS
    SENSI, M
    DEROSSI, MG
    CRISTINA, A
    VALLE, E
    OLIVA, A
    ANDREANI, D
    DIMARIO, U
    DIABETOLOGIA, 1993, 36 : A191 - A191
  • [35] Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy
    Jack, Megan
    Wright, Douglas
    TRANSLATIONAL RESEARCH, 2012, 159 (05) : 355 - 365
  • [36] Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice
    Rubin, Mishaela R.
    Paschalis, Eleftherios P.
    Poundarik, Atharva
    Sroga, Gyna E.
    McMahon, Donald J.
    Gamsjaeger, Sonja
    Klaushofer, Klaus
    Vashishth, Deepak
    PLOS ONE, 2016, 11 (05):
  • [37] Advanced glycation endproducts and polysialylation affect the turnover of the neural cell adhesion molecule (NCAM) and the receptor for advanced glycation endproducts (RAGE)
    Frank, Franziska
    Bezold, Veronika
    Bork, Kaya
    Rosenstock, Philip
    Scheffler, Jonas
    Horstkorte, Ruediger
    BIOLOGICAL CHEMISTRY, 2019, 400 (02) : 219 - 226
  • [38] Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD
    Meijer, Berrie
    Hoskin, Teagan
    Ashcroft, Anna
    Burgess, Laura
    Keenan, Jacqueline I.
    Falvey, James
    Gearry, Richard B.
    Day, Andrew S.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (06): : 513 - 520
  • [39] Receptor for advanced glycation endproducts and progressive kidney disease
    Fukami, Kei
    Taguchi, Kensei
    Yamagishi, Sho-ichi
    Okuda, Seiya
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (01): : 54 - 60
  • [40] The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
    Yan, Shi Fang
    Ramasamy, Ravichandran
    Schmidt, Ann Marie
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11